Past News Releases
RSSDallas, TX (PRWEB) March 12, 2013
This comprehensive market report has primarily focused on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein. The report provides primary industry data that it has collected as part of its continual industry tracking of this space.
The report analysis clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. The report also presents the breakout of clinical trials in the bonafide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
The report “Cellular Therapy and Cord Blood 2013 Market Report” also provides a detailed quantitative analysis of the cord blood field as it is rapidly evolving. The report provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood. Furthermore, the report has been able to compare the EU and US markets side-by-side in this analysis.
The report also presents the ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union. Details on the statute as well as implications to companies seeking to navigate this space are provided.
Extensive Market Analyses Presented in this Report:
- Regenerative Medicine and Stem Cell Research Activity in the US
- Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
- Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
- Breakout of Spending by Product Platforms in Various Spaces
- Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
- Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
- Adult Stem Cell Therapy Quantitative Market Forecast
- Cellular Therapy Product Pipeline
- Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic
Areas Addressed, Geography
- HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
- Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
- Cost Analyses of HSCTs in the EU vs. US Markets
- Cord Blood Banking Quantitative Market Metrics
- Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
- Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
- EU and US Cord Blood Transplantation Detailed Cost Breakouts
- EU ATMP Regulation Detailed Analysis
- Stem Cells Worldwide Publications Analysis
Buy a copy of this report @ http://www.reportsnreports.com/purchase.aspx?name=225107.
Table of Contents:
Chapter I Cellular Therapeutics Market Landscape
Chapter II Cord Blood Market Landscape
Chapter III Stem Cell Opportunities and Funding Sources in Some of the Top Markets across the European Union
Chapter IV ATMP Regulatory Routes for Approval of Cellular Therapies in the European Union
Explore more reports Biotechnology Market and Stem Cell Market.
About US:
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.